Professor Claude M. Wischik, co-founder and Executive Chairman of TauRx Therapeutics, along with colleagues at the University of Aberdeen, has devoted nearly 30 years to investigating the structure and role of tau tangles in the development of Alzheimer’s, frontotemporal dementia and other neurodegenerative diseases. Prof. Wischik discovered that the neurofibrillary tangles seen in Alzheimer’s disease are made of sub-units of the tau protein and he and his team have published extensively in the field.
Filter by yearAll 2022 2021 2020 2019 2018 2017 2016 2015 2014 2012 2011 2010 2009 2008 2007 2006 2005 2001 2000 1998 1997 1996 1995 1994 1993 1992 1991 1990 1988 1986 1985
Bondareff, W. et al. (1994) Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease. Available at Journal of Neuropathology & Experimental Neurology
Bondareff, W. et al. (1994) Presence of axonal paired helical filament tau in Alzheimer's disease: submicroscopic localization. Available at Journal of Neuroscience Research
Harrington, C.R., et al. (1994) Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients. Available at Lancet
Harrington, C.R., et al. (1994) Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Available at American Journal of Pathology
Harrington, C.R., et al. (1994) Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Available at Dementia